• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

February 11, 2019
Company Drug/Device Medical Condition Status
AtriCure, Inc. cryoICE Ablation System atrial fibrillation (Afib) Phase I trial initiated enrolling up to 150 subjects at up to 20 centers in the U.S. with persistent and long-standing persistent atrial fibrillation undergoing cardiac surgical procedure(s) for heart valve repair or replacement and/or coronary artery bypass procedures
Verseon VE-1902 coronary artery disease Phase I trial initiated enrolling 100-120 healthy volunteers
Actinium Pharmaceuticals, Inc. Actimab-A and venetoclax Acute Myeloid Leukemia (AML) Phase I/II trial initiated enrolling subjects with relapsed or refractory AML that have been previously treated with venetoclax and subjects that have never received venetoclax
Orphan Technologies OT-58 classical homocystinuria Phase II trial initiated enrolling up to 20 subjects
Neurana Pharmaceuticals tolperisone acute muscle spasms of the back Phase II trial initiated enrolling 400 subjects
BioLineRx Ltd. BL-8040 pancreatic cancer Orphan Drug Designation granted by the FDA
REGENXBIO, Inc. RGX-181 late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
disease
Rare Pediatric Disease Designation granted
by the FDA
Pharnext SA PXT3003 Charcot-Marie-Tooth disease Type 1A (CMT1A) Fast Track Designation granted by the FDA
Teleflex Incorporated MANTA Vascular Closure Device large bore femoral arterial access site closure PMA granted by the FDA
Flowonix Medical, Inc. Flowonix Maestro Software for Clinician Programmers used to program Prometra Pump Systems intrathecal infusion
of drug therapy
Approval granted by the FDA
Cook Medical Zenith Dissection Endovascular System Type B dissections of the descending thoracic aorta Approval granted by the FDA
Mylan N.V. generic Advair Diskus (fluticasone propionate and salmeterol inhalation powder) twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) Approval granted by the FDA

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing